You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,780,987

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 7,780,987 protect, and when does it expire?

Patent 7,780,987 protects GLUMETZA and is included in one NDA.

This patent has twenty-six patent family members in fourteen countries.

Summary for Patent: 7,780,987

Patent landscape, scope, and claims:

Title:	Controlled release dosage forms
Abstract:	The invention provides stable controlled release monolithic coating compositions for use in coating pharmaceutical oral dosage forms comprising a polyglycol having a melting point greater than 55.degree. C. and an aqueous dispersion of a neutral ester copolymer lacking functional groups.
Inventor(s):	Zhou; Fang (Centreville, VA), Maes; Paul (Potomac, MD)
Assignee:	Biovail Laboratories International SRL (St. Michael, BB)
Application Number:	10/370,109
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,780,987
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form; Process; Use;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 7,780,987

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Santarus Inc	GLUMETZA	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021748-002	Jun 3, 2005	AB3	RX	Yes	Yes	7,780,987	⤷ Subscribe	Y	Y			⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 7,780,987

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	536173	⤷ Subscribe
Australia	2003211145	⤷ Subscribe
Australia	2003211146	⤷ Subscribe
Canada	2476201	⤷ Subscribe
Canada	2476496	⤷ Subscribe
Cyprus	1112517	⤷ Subscribe
Denmark	1476138	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.